CD7 in acute myeloid leukemia: Correlation with loss of wild-type CEBPA, consequence of epigenetic regulation

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Röhrs, Sonja ^a   Scherr, Michaela ^b   Romani, Julia ^a   Zaborski, Margarete ^a   Drexler, Hans G ^a   Quentmeier, Hilmar ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CD7 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BINDING SITE; CONTROLLED STUDY; EPIGENETICS; EXON; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; DNA METHYLATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTIGENS, CD7; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 77950678562     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-15     Document Type: Article

References (18)

1. CCAAT/Enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. HS Radomska CS Huettner P Zhang T Cheng DT Scadden DG Tenen, Mol Cell Biol 1998 18 4301 4314 9632814
2. PU.1 (Spi-1) and C/EBP regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. LT Smith S Hohaus DA Gonzalez SE Dziennis DG Tenen, Blood 1996 88 1234 1247 8695841
3. Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBP A Iwama P Zhang GJ Darlington SR McKercher R Maki DG Tenen, Nucleic Acids Res 1998 26 3034 3043 10.1093/nar/26.12.3034 9611252
4. C/EBP, c-Myb, and PU.1 cooperate to regulate the Neutrophil Elastase Promoter. M Oelgeschläger I Nuchprayoon B Lüscher AD Friedman, Mol Cell Biol 1996 16 4717 4725 8756629
5. C/EBP and the pathophysiology of acute myeloid leukemia. BU Mueller T Pabst, Curr Opin Hematol 2006 13 7 14 10.1097/01.moh.0000190110.08156.96 16319681
6. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancing binding protein-(C/EBP), in acute myeloid leukemia. T Pabst BU Mueller P Zhang HS Radomska S Narravula S Schnittger G Behre W Hiddemann DG Tenen, Nature Genet 2001 27 263 270 10.1038/85820 11242107
7. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. BJ Wouters MA Jord K Keeshan I Louwers CAJ Erpelinck-Verschueren D Tielemans AW Langerak Y He Y Yashiro-Ohtani P Zhang CJ Hethereington RGW Verhaak PJM Valk B Löwenberg DG Tenen WS Pear R Delwel, Blood 2007 110 3706 3714 10.1182/blood-2007-02-073486 17671232
8. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. LI Lin CY Chen DT Lin W Tsay JL Tang YC Yeh HL Shen FH Su M Yao SY Huang HF Tien, Clin Cancer Res 2005 11 1372 1379 10.1158/1078-0432.CCR-04-1816 15746035
9. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. H Chang F Salma Q Yi B Patterson B Brien MD Minden, Leukemia Res 2004 28 43 48 10.1016/S0145-2126(03)00180-2 (Pubitemid 37433792)
10. Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes. C Satoh H Tamura T Yamashita T Tsuji K Dan K Ogata, Leukemia Res 2009 33 326 331 10.1016/j.leukres.2008.07.006
11. c-Myc is a critical target for C/EBPa in granulopoiesis. LM Johansen A Iwama TA Lodie K Sasaki DW Felsher TR Golub DG Tenen, Mol Cell Biol 2001 21 3789 3806 10.1128/MCB.21.11.3789-3806.2001 11340171
12. CpG islands in vertebrate genomes. M Gardiner-Garden M Frommer, J Mol Biol 1987 162 261 282 10.1016/0022-2836(87)90689-9
13. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. M Weber I Hellmann MB Stadler L Ramos S Pääbo M Rebhan D Schübeler, Nature Genetics 2007 39 457 466 10.1038/ng1990 17334365
14. Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia. SL Rogers Y Zhao X Jiang CJ Eaves DL Mager A Rouhi, Mol Cancer 2010 9 41 10.1186/1476-4598-9-41 20175919
15. HG Drexler, Guide to Leukemia-Lymphoma Cell Lines Braunschweig 2005
16. BiQ analyser: visualization and quality control for DNA methylation data from bisulfite sequencing. C Bock S Reither T Mikeska M Paulsen J Walter T Lengauer, Bioinformatics 2005 21 4067 4068 10.1093/bioinformatics/bti652 16141249
17. SET-NUP214 fusion in acute myeloid leukemia-and T-cell acute lymphoblastic leukemia-derived cell lines. H Quentmeier B Schneider S Röhrs J Romani M Zaborski RAF MacLeod HG Drexler, J Hematol Oncol 2009 2 3 10.1186/1756-8722-2-3 19166587
18. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. M Scherr K Battmer A Ganser M Eder, Cell Cycle 2003 2 3 251 257 12734435